ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 82 filers reported holding ACLARIS THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $2,371,000 | -56.1% | 135,000 | -37.0% | 0.04% | -58.4% |
| Q1 2021 | $5,400,000 | +248.6% | 214,300 | -10.5% | 0.10% | +206.1% |
| Q4 2020 | $1,549,000 | +119.7% | 239,400 | -12.8% | 0.03% | +106.2% |
| Q3 2020 | $705,000 | +58.4% | 274,400 | 0.0% | 0.02% | +77.8% |
| Q2 2020 | $445,000 | +169.7% | 274,400 | +213.6% | 0.01% | +350.0% |
| Q4 2019 | $165,000 | +73.7% | 87,500 | 0.0% | 0.00% | +100.0% |
| Q3 2019 | $95,000 | -50.5% | 87,500 | 0.0% | 0.00% | -50.0% |
| Q2 2019 | $192,000 | – | 87,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 1,954,904 | $49,264,000 | 43.26% |
| COMMODORE CAPITAL LP | 1,028,084 | $25,908,000 | 10.32% |
| Foresite Capital Management IV, LLC | 3,399,034 | $85,656,000 | 10.26% |
| VR Adviser, LLC | 3,720,582 | $93,759,000 | 10.17% |
| Parkman Healthcare Partners LLC | 1,709,136 | $43,070,000 | 10.00% |
| Foresite Capital Management V, LLC | 1,258,243 | $31,708,000 | 9.32% |
| Stenahm Asset Managment Ltd | 283,500 | $7,144,000 | 5.04% |
| Samsara BioCapital, LLC | 1,022,612 | $25,770,000 | 4.75% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 336,737 | $8,486,000 | 4.63% |
| Ghost Tree Capital, LLC | 600,000 | $15,120,000 | 3.55% |